List of Cases |
International
Business (English Language) 3k. |
|
|
|
Presentations
submission timeliness, slide quality, oratorical art, audience involvement in
the case study 0-3 |
The complexity of
the analyzed problem 0-3 |
Case studies
breadth, i.e. quite a lot of work done 0-4 |
Depth of the case
analysis, i.e. use sophisticated analytical techniques 0-4 |
It was collected an
additional, interesting and valuable material on the Internet 0-2 |
A summary of the
findings, what is memorable, the most valuable of the case presented, where
you can apply the acquired knowledge 0-2 |
Working as opponent of the peer
presentations or active participation in the cases analysis 0-1. Good questions or comments prized pluses,
3-4 pluses equal to 1 point. |
|
|
|
|
|
|
|
|
|
|
# |
Page |
Case |
The names
of students who analyzed the case |
Date of
presentation |
Presentations
queue |
Slides of
the presentation |
Additional material 1 |
Additional material 2 |
Assessment
of case study |
1 |
365-369 |
Lockheed company |
Elif Ilayda Ince |
2023-04-18 |
4 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
365-369 |
Lockheed company |
Alex Quintana |
2023-04-18 |
4 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
365-369 |
Lockheed company |
Ieva Jankauskyte |
2023-04-18 |
4 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
365-370 |
Lockheed company |
Nikita Kuzmin |
2023-04-18 |
|
|
|
|
0 |
|
|
|
|
|
|
|
2 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Yuliya Mironava |
2023-04-11 |
1 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Anhelina Valkavets |
2023-04-11 |
1 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Aliaksandra Lepesevich |
2023-04-11 |
1 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
3 |
377-379 |
Tree Values |
Lucia Campos |
2023-05-02 |
1 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
377-379 |
Tree Values |
Alejandro de la Hera |
2023-05-02 |
1 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
377-379 |
Tree Values |
Andrea Navas |
2023-05-02 |
1 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
4 |
381-394 |
The Super Project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
381-394 |
The Super project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
381-394 |
The Super project |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
5 |
395-403 |
Net Flix |
Ugnė
Urbonavičiūtė |
2023-04-25 |
8 |
|
|
|
8 |
2 |
2 |
1 |
|
1 |
2 |
|
|
395-403 |
Net Flix |
Domantas Šeimys |
2023-04-25 |
8 |
|
|
|
8 |
2 |
2 |
1 |
|
1 |
2 |
|
|
395-403 |
Net Flix |
Rusnė
Rimaitė |
2023-04-25 |
8 |
|
|
|
8 |
2 |
2 |
1 |
|
1 |
2 |
|
|
395-404 |
Net Flix |
Lukaš
Dzisevič |
2023-04-25 |
8 |
|
|
|
8 |
2 |
2 |
1 |
|
1 |
2 |
|
6 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Tadas
Bugailiskis |
2023-04-25 |
7 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
ignas galvicius |
2023-04-25 |
7 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
405-418 |
A-Rod: Signing the Best Player in Baseball |
Jan-Kaspar
Steves |
2023-04-25 |
7 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
7 |
419-423 |
Ocean Carriers |
Martynas Jurgis Bireta |
2023-05-02 |
4 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
419-423 |
Ocean Carriers |
Todd Tautvydas Donnelly |
2023-05-02 |
4 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
419-423 |
Ocean Carriers |
Aivaras Kuzmicka |
2023-05-02 |
4 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
8 |
405-418 |
Whirlpool Europe |
Deimantė Bakaitytė |
2023-04-25 |
3 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
405-418 |
Whirlpool Europe |
Prethela Sarker |
2023-04-25 |
3 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
405-418 |
Whirlpool Europe |
Karolina Visockytė |
2023-04-25 |
3 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
9 |
431-434 |
Health Development Corporation |
Agne Mazeikaite |
2023-04-25 |
5 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
431-435 |
Health Development Corporation |
Alina Pancerova |
2023-04-25 |
5 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
431-436 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
10 |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
Christian Barbarisi |
2023-04-18 |
2 |
|
|
|
9 |
3 |
2 |
2 |
|
|
2 |
|
|
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
Sum Yee Chan (Serena) |
2023-04-18 |
2 |
|
|
|
10 |
3 |
2 |
2 |
|
|
2 |
1 |
|
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
Andrea Carolina Ramirez Salaverria |
2023-04-18 |
2 |
|
|
|
10 |
3 |
2 |
2 |
|
|
2 |
1 |
11 |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
Ugnius Kęstauskas |
2023-04-25 |
2 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
Boris Kim |
2023-04-25 |
2 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
Kornelijus Ruskonis |
2023-04-25 |
2 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
260 |
Worldwide Paper Company
(Analysis of an expansion investment) |
Daniel Voiciukevič |
2023-04-25 |
2 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
12 |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Aistė Stračinskytė |
2023-05-02 |
2 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Ugnius Vainevičius |
2023-05-02 |
2 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Ričardas Ratkevičius |
2023-05-02 |
2 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Liudas Vaitiekūnas |
2023-05-02 |
2 |
|
|
|
7 |
|
2 |
2 |
|
1 |
2 |
|
13 |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Liutauras Velicka |
2023-04-25 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Justina
Sahmel |
2023-04-25 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
283 |
Aurora Textile Company
(Analysis of an automation investment) |
Glorija Kaminskaite |
2023-04-25 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
284 |
Aurora Textile Company
(Analysis of an automation investment) |
Emilija Vanceviciute |
2023-04-25 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
14 |
295 |
Compass Records (Analysis
of working capital investment) |
Tianqi Xu |
2023-05-02 |
5 |
|
|
|
7 |
1 |
2 |
2 |
|
1 |
1 |
|
|
295 |
Compass Records (Analysis
of working capital investment) |
Taghiyev Dildar |
2023-05-02 |
5 |
|
|
|
7 |
1 |
2 |
2 |
|
1 |
1 |
|
|
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
15 |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
KA WING WONG |
2023-04-25 |
6 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
HAOFENG LIN |
2023-04-25 |
6 |
|
|
|
9 |
2 |
2 |
2 |
|
1 |
2 |
|
|
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
16 |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
17 |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
Justas Sadauskas |
2023-04-18 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
Ieva
Poniškaitytė |
2023-04-18 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
Tautvydas Telyčėnas |
2023-04-18 |
1 |
|
|
|
10 |
2 |
2 |
2 |
|
1 |
2 |
1 |
18 |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|